Condition: Liver Cirrhosis · Sponsor: Medical University of Vienna
Out of fear of bleeding, liver cirrhosis patients are often treated prophylactically with blood and coagulation products before minor interventions. The COUCH study will examine whether these patients benefit from a restrictive administration of coagulation products.
This description comes directly from the study's public registry record.
Armin Langauer, MD · +43 1 40400 41000 · armin.langauer@meduniwien.ac.at
Kristina Nieding, MD · +43 1 40400 41000 · kristina.nieding@meduniwien.ac.at
Always discuss trial participation with your own doctor first.
| General Hospital of the Medical University of Vienna | Vienna, Austria | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05667805